ALKERMES | ALKS - Market Capitalization



ALKERMES reported $4.68B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
AbbVie USD 327.88B 42.76B Jun/2025
Acadia Pharmaceuticals USD 3.61B 840M Jun/2025
ALKERMES USD 4.72B 725M Jun/2025
Amgen USD 150.13B 17.37B Jun/2025
Biogen USD 18.41B 1.62B Jun/2025
BioMarin Pharmaceutical USD 10.54B 3.01B Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Eli Lilly USD 738.79B 2.87B Jun/2025
Gilead Sciences USD 137.91B 1.77B Jun/2025
Ionis Pharmaceuticals USD 6.29B 1.49B Jun/2025
J&J USD 366.71B 32.94B Jun/2025
Merck USD 198.77B 27.1B Jun/2025
Neurocrine Biosciences USD 12.44B 1.5B Jun/2025
Otsuka Holdings JPY 3.88T 396.93B Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Regeneron Pharmaceuticals USD 55.87B 13.47B Jun/2025
Vertex Pharmaceuticals USD 114.33B 10.31B Jun/2025